Skip to main content
. 2019 Feb 7;9:1583. doi: 10.1038/s41598-018-38272-1

Table 1.

Comparison of tumor-infiltrating lymphocytes grades in primary and residual tumors after neoadjuvant chemotherapy with trastuzumab.

TILs grade Pretreatment tumors Residual tumors
N % N %
Low (TILs, 0% to 10%) 66 51.6 28 62.2
Intermediate (TILs, 10% to 40%) 38 29.7 8 17.8
High (TILs, 40% to 90%) 24 18.8 9 20.0
Total 128 100 45 100

Abbreviations: TILs: tumor-infiltrating lymphocytes.